ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag flu vaccine genetics genomics developmental biology

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
H5N1 vaccine strain in a week
Robert Walgate(walgate@scienceanalysed.com) | Jan 28, 2004 | 3 min read
Using reverse genetics, WHO thinks a prototype bird flu strain likely to be ready in a week
Bird Flu Transmission in Mammals
Ruth Williams | May 2, 2012 | 3 min read
After much ado, Nature publishes the first report of a bird flu virus adapted for transmission in ferrets.
Advances in the functional characterization of newly discovered microproteins hint at their diverse roles  in health and disease
The Dark Matter of the Human Proteome
Annie Rathore | Apr 1, 2019 | 10 min read
Advances in the functional characterization of newly discovered microproteins hint at diverse roles in health and disease.
Top 7 in Evolutionary Biology
Jef Akst | Nov 29, 2011 | 3 min read
A snapshot of the most highly ranked articles in evolutionary biology and related areas, from Faculty of 1000
Characterizing H7N9
Kate Yandell | Apr 26, 2013 | 6 min read
What scientists are learning about the zoonotic flu virus that has infected more than 100 people in China since February
Spraying spray bottle
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward
Jef Akst | Jun 13, 2022 | 10+ min read
Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?
istock image 800x560
Can mRNA Vaccine Momentum Propel Tumor Immunotherapies?
Aparna Nathan, PhD | Nov 12, 2021 | 4 min read
A guide to mRNA-based cancer vaccines and where they’re headed next
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
New Era in Vaccine Development
Nadia Halim | Apr 16, 2000 | 6 min read
When all fails, try a new attack. That's exactly what researchers do when they use genome sequence data to develop vaccine candidates against the most difficult pathogenic adversaries. Recent efforts are revealing previously unknown microbial genes that may encode proteins important in triggering immunity. "Whole-genome data provides insight into all the features of [organisms] including access to virtually every single antigen that may provoke an immune response," explains Michael Gottlieb, pa

Run a Search

ADVERTISEMENT